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Purpose: To investigate the prevalence of chronic pain and its association with health-
related quality of life (HRQoL) in a group of women, diagnosed with autism spectrum
disorder (ASD) and/or attention deficit hyperactive disorder (ADHD) in childhood.
Patients and methods: Prospective longitudinal 16–19 years follow-up study of 100
Swedish females diagnosed with ASD and/or ADHD in childhood/adolescence. Seventy-
seven of the women were included in the current sub-study, using validated measures of pain
perception and quality of life.
Results: A large majority of the women (76.6%) reported chronic pain. HRQoL was low
overall and lower still for those reporting chronic pain. Women with ADHD who had
ongoing treatment with stimulants reported a significant lower prevalence of chronic wide-
spread pain (CWP) than those not treated.
Conclusion: Comorbidity with chronic pain is common in women with ASD and/or ADHD
and important to address in the clinic since it is associated with an already low HRQoL.
Treatment for ADHD might reduce the pain in some cases.
Keywords: female, girls, attention deficit disorder, autism spectrum disorder, widespread
pain, stimulants
Introduction
ADHD and ASD have been reported to be predominantly male conditions, but
recent research shows that females are much more frequently affected than pre-
viously believed.1–3
ADHD is a common disorder affecting 4–7% of school-aged children, and
symptoms usually persist into adulthood.4,5 The prevalence of ASD is estimated
at about 1%.6 ASD is generally considered to be a lifelong disability.
The male:female ratio in ADHD is now estimated at about 1.6:1.1 The correspond-
ing ratio in ASD is probably also less than previously assumed.7 In a recent review, it
was concluded that for children meeting criteria for ASD, the ratio is close to 3:1.6
Recent epidemiological surveys have reported even lower male bias, 2.0–2.6:1, in the
prevalence of ASD in the general population.2,3
Compared with men/boys with ADHD,women/girls with ADHD aremore prone to
have difficulties with inattentive symptoms than with hyperactive and impulsive
symptoms, and they often receive a diagnosis of ADHD significantly later than their
male counterparts.8 Girls who meet criteria for ASD are at disproportionate risk of
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delayed diagnosis, or remaining undiagnosed, in comparison
to their male peers. Many adult women who would meet full
diagnostic criteria for ASD never receive a diagnosis and the
help that might come with it.9
In an Australian study examining gender differences
among children meeting symptom criteria for ADHD,
boys and girls did not differ on core symptoms, comorbid-
ity, and impairment with the exception that girls rated
higher on somatic complaints.10 Daalsgard et al showed
that ADHD is associated with increased mortality, which
is more pronounced in women and is highest in individuals
diagnosed in adulthood.11 Elevated risk for suicide
attempts and self-injury has also been demonstrated com-
pared with women in general.12
Until recently, there have only been a few published
studies about adult life among individuals with ASD. The
studies show a wide variability in outcomes. The role of
gender remains uncertain as most studies involve few
women. Moreover, there are methodological problems in
conducting research of lifetime outcomes for individuals
with a condition as heterogeneous as autism.13 In a register
linkage study, findings indicate that nearly all major
chronic medical and psychiatric conditions are signifi-
cantly more common in the ASD group. Suicide attempt
rates are five times higher than in patients without any
autism spectrum disorder diagnoses.14 Premature mortality
was markedly increased in ASD owing to a multitude of
medical conditions; women had a higher relative mortality
risk than men due to endocrine diseases, congenital mal-
formations, and suicide.15
In a clinical setting, there is a common occurrence of
overlapping symptoms of ADHD in ASD cases and clear
traits of autism in ADHD.16 Comorbid disorders are fre-
quent in individuals with ADHD and ASD.1 This results in
a complexity when conducting surveys in these groups.
Chronic pain is a common, complex, and challenging
condition. Pain is considered chronic when persistent or
recurrent for more than three months. Based on the dis-
tribution of pain in the body, the condition can be defined
as chronic widespread pain (CWP) or chronic regional
pain (CRP). The definition of CWP according to the
American College of Rheumatology (ACR) is that muscu-
loskeletal pain should be present in both sides of the body,
above and below the waist and in the axial skeleton. The
more often studied condition fibromyalgia is a subgroup of
CWP, characterized by CWP in combination with tender-
ness at 11 or more of 18 specific tender point sites, often
combined with fatigue and cognitive impairment.17
Globally CWP affects one in ten individuals within the
general population, with women more likely to be affected
than men.18 A Swedish survey of a representative sample
of the general adult population showed an age-adjusted
prevalence about twice as great for women (15.3%), as for
men (7.5%).19 There is evidence of excess mortality
among persons with CWP.20
Several studies indicate that chronic pain is an issue for
adolescents with emotional or behavioural problems21 and
for women with ADHD symptoms.22,23 There are also
some studies investigating the high frequency of ADHD
found among patients with fibromyalgia.24–26 In a recent
qualitative study on the perception of health professionals
on frequency of painful symptoms among women with
ADHD, most respondents had noted a correlation.27
Prospective clinical studies are lacking. Studies related to
ASD and chronic pain appear to be scarce.
Health-related quality of life (HRQoL) is a subjective
and multidimensional construct dealing with how health
affects the physical, psychological, and social wellbeing of
an individual. Both ASD, ADHD, and CWP are known to
affect HRQoL negatively.28–30
The aim of this study was to investigate the prevalence
of chronic pain in a group of women, with a childhood
diagnosis of ASD and/or ADHD. A second objective was
to assess HRQoL in this group of women and the possible
association of chronic pain on HRQoL.
Materials And Methods
Study Population
This is a part of a longitudinal 16–19 years follow-up
study of a comprehensively examined cohort of females
conducted in Gothenburg, Sweden. Between 1999 and
2001, 100 girls aged 3 through 18 years were examined
at the Child Neuropsychiatric Clinic, Queen Silvia’s
Children and Youth Hospital. The girls had been referred
due to social impairment, attention/academic deficits, and/
or tics. Exclusion criteria included previously diagnosed
learning disabilities, severe physical disorders, and/or par-
ents lacking adequate command of Swedish. The investi-
gation was multi-professional, performed by very
experienced clinicians, and the total number of hours
spent by the girls in the assessment clinic exceeded 20
hrs in all cases. The diagnosis of ADHD and ASD, respec-
tively, was made in accordance with the criteria of DSM-
IV. Of the 100 girls, 46 were diagnosed with ASD with or
without co-existent ADHD and 46 had a main diagnosis of
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ADHD without ASD. Of the remaining 8, 3 had tic dis-
orders and 5 had other psychiatric disorders. In the whole
group, 12 were found to actually meet criteria for learning
disabilities (after psychometric testing, in spite of having
originally been “screened negative” for this disability) (see
reference Kopp et al16 for more details).
During the years 2015–2018, the previously diagnosed
women, now 19–37 years old, were contacted by mail,
informing them about the planned study. Subsequently,
they were all contacted by telephone for supplementary
information before they were asked to decide on partici-
pating in the study. Four women could not be reached, and
five directly declined participation. Of the 91 remaining
women, 9 did not want to participate or were not able to
participate on their own. However, they all gave permis-
sion for an interview with a close relative (usually the
mother). Two of the women gave oral information about
their present status and could be included in the study, but
did not complete any questionnaires. All 91 subjects
included provided informed consent.
The women were examined using 16 different instru-
ments, some of which are semi-structured interviews. The
majority of questionnaires were completed during a single
interview. All three interviewers were physicians who
were clinically experienced in the assessment and treat-
ment of ASD and/or ADHD.
The present study reports on results obtained regarding
self-reported estimation of pain localization and duration
and self-reported HRQoL. Of the 91 women included in
the main study, 80 completed questionnaires regarding
pain and HRQoL; of those, 77 had a main or second
diagnosis of ASD or ADHD and were included in the
study. The three excluded women had diagnoses of
Tourette syndrome, learning disorder, and sleep disorder.
Information regarding ongoing treatment with stimu-
lants and possible care contacts were taken from the semi-
structured interview regarding the current life situation.
Questionnaires
To document experienced pain, a template with 18 prede-
fined body regions was used. It was designed according to
the ACR definition of CWP and has been used in previous
studies.31 The interviewed women were asked to tick
boxes on the figure to mark all body parts where they
had experienced pain for more than 3 months during the
last 12 months. CWP was considered present when mus-
culoskeletal pain for more than 3 months was described
for both sides of the body, above and below the waist and
in the axial skeleton. Pain lasting more than 3 months not
fulfilling criteria for CWP, was considered as chronic
regional pain (CRP).17 Those not fulfilling criteria for
CRP or CWP were considered to have no chronic
pain (NCP).
The head and the abdomen were not included in the
template. Thus, the questionnaire was supplemented with
the following question: “Did you have any other pain that
lasted more than 3 months in the last 12 months (eg, head
and abdomen)?”. Free text responses were categorized as
headache or abdominal pain. These results are reported
separately and are not included in the category musculos-
keletal chronic pain.
The Short-Form Health Survey (SF-36) was used to
estimate HRQoL. SF-36 is a 36 item short form, originally
constructed for the Medical Outcome study.32 The
Swedish version was translated and adapted as part of
the International Quality of Life Assessment (IQOLA)
Project.33 The SF-36 is a well-validated, often used health
status instrument. In a follow-up study of males with ASD,
SF-36 was one of the instruments used to examine sub-
jective quality of life with satisfactory results.34 In studies
assessing HRQoL in adults with ADHD, SF-36 has fre-
quently been used and validated.29
SF-36 measures eight different health concepts: physi-
cal functioning (PF), role function-physical aspect (RP),
bodily pain (BP), general health perception (GH), vitality
(VT), social functioning (SF), role function-emotional
aspect (RE), and mental health (MH). SF-36 provides a
score between 0 and 100 for each of the eight health
concepts, where a higher score implies better health.
These eight concepts measure the two major dimensions
of health: physical and mental.35,36
Results in the present study group were compared to those
in a population study performed in Halland, Sweden, 1995.19
Ethics
The central Ethical Review board of the University of
Gothenburg has approved the study (855–14, 2015-02-17).
Participation in the study was voluntary, and a written
informed consent was obtained from each participant.
Special arrangements were required to ensure that potential
participants were fully informed. Women with ASD some-
times get stuck in formulations in the research project
description and those with ADHD may experience concen-
tration difficulties. Further, some of the women were known
to have dyslexia. After feedback from the first eight parti-
cipants, we realized the need for simplified study
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information. Thus, a simplified version of the letter was sent
to complement the formal invitation. Oral information was
provided to ensure that all participants understood what the
interview/assessment would entail.
Statistics
The statistical analyses were done with IBM SPSS
Statistics 23 software. T-tests were used for group compar-
isons of means. Chi-square tests were used for compari-
sons of proportions across groups. A p-value of less than
0.05 was considered statistically significant.
Results
The 77 women included in the study were born between
1981 and 1998, and they were between 19 and 37 years
old at follow-up with a mean age of 27.2 (SD 4.2) years.
At inclusion, in childhood, 34 (44.2%) of the women were
diagnosed with ASD as a main diagnosis. Of these, 31 had
ADHD as a second diagnosis. Forty-one (53.2%) had
ADHD as a main diagnosis. Two women were diagnosed
with Tourette syndrome or mild mental retardation as main
diagnoses but fulfilled criteria for ADHD as second diag-
nosis. Women with ADHD as a main diagnosis were
significantly older than those with ASD (29.1 and 25.0,
respectively; p<0.001). Thirty-three of the women with
another main diagnosis at inclusion also fulfilled criteria
for ADHD as well, giving a total of 74 women (96.1%)
fulfilling the criteria in childhood.
Chronic pain was reported by 59 (76.6%) of the
women and the prevalence of CWP was 32.5%. CWP
was reported by 23.5% of those with a main diagnosis of
ASD and 39.0% of those with a main diagnosis of ADHD
(p=0.313). The distribution of pain type by main diagnosis
is visualized in Figure 1. There was no difference between
women with a main diagnosis of ASD or ADHD with
regard to reported number of painful regions (2.9 and
3.6, respectively; p=0.355). The most common location
of pain was in the lower back, reported by 46.8%, fol-
lowed by the neck and shoulders (Table 1).
In the entire group of women, 20 (26.0%) reported
problems with recurrent headache, 23 (29.9%) reported
abdominal pain, and 11 (14.3%) reported both headache
and abdominal pain. There were no statistically significant
differences between those with ASD and those with
ADHD as main diagnosis with regard to abdominal pains
(29.4% and 31.7%, respectively; p=0.830) or headache
Figure 1 Pain type distribution (NCP, CRP, CWP) at follow-up by main diagnosis (ASD, ADHD, Other) at inclusion in childhood, presented as number of individuals.
Asztély et al Dovepress
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(20.6% and 31.7%, respectively; p= 0.278). Headache was
present in 55.0% of those with CWP, 30.4% in CRP and
15.0% in NCP (p=0.044). Abdominal pain was present in
47.8% of those with CWP, 30.4% in CRP and 21.7% in
NCP (p=0.148). Of the women with CWP, 8 (32.0%)
reported both headache and stomach pain, compared to 3
(5.8%) of the women with CRP or NCP (p=0.004).
HRQoL in the study population was overall signifi-
cantly (p<0.001) lower in all eight SF-36 health concepts
compared with age- and sex-specific norms.37 Those with
NCP did not differ from the normal population regarding
the physical dimensions of the health concepts (PF, RP,
GH, and VT) but significantly - and clinically relevant -
regarding the mental dimensions (SF, RE, and MH). When
analyzing differences between the three pain groups (NCP,
CWP, and CRP), there were significant and clinically
relevant differences for PF, BP, GH, and VT, but not for
RP, SF, RE, or MH (Table 2) (Figure 2).
Out of those with ADHD as a main or secondary
diagnosis (n=74), 24 (32.4%) had ongoing treatment with
stimulants. This group reported a lower prevalence of
CWP than those not treated with stimulants (16.7% and
42.0%, respectively; p=0.031). There was no difference in
the prevalence of CWP in those with ADHD that had a
regular contact with primary or psychiatric care clinics
(32.1%) compared to those who had not (32.1% and
38.1%, respectively; p=0.622).
Discussion
Chronic pain was very common in this longitudinally fol-
lowed cohort of females diagnosed in childhood with ASD/
ADHD and assessed 16–18 years after initial diagnosis.
HRQoL, as measured by SF-36, was lower than in the gen-
eral population and even lower for those reporting CWP.
Chronic pain was reported by three-quarters of the
women in the study, a proportion three times that of
same-age women in the Swedish population. Widespread
pain was observed in a third of the women, a figure five
times that is seen in the same-age female population.19
The proportion with chronic pain was numerically greater
in women with a main diagnosis of ADHD at the start of
the study as compared with those with a main diagnosis of
ASD, the difference, however, was not significant. This
might in part be due to the relatively small sample size.
Another consideration is the fact that most of the women
in the ASD group also met the criteria for ADHD.
The prevalence of chronic pain in women previously
diagnosed with ASD and/or ADHD in our study (76.6%)
was considerably higher than that found in the large,
nationally representative 2012 Canadian Community
Health Survey – Mental Health (28.0%).22 Part of the
disparity can probably be explained by methodological
differences. In the Canadian study, the women were inter-
viewed by telephone, and asked “are you usually free of
pain or discomfort?”. The diagnosis of ADHD was self-
reported by 2.6% of the women and there are no informa-
tion on data loss.
A co-variation between pain and ASD/ADHD diag-
noses was also found in a Swedish study performed by
Lisker et al.38 In a sample of 146 paediatric chronic pain
patients (referred to a tertiary pain clinic), 38 of the
Table 1 Locations Of Chronic Pain At Follow-Up In All 77
Included Women
n %
Chest 3 3.9
Neck 29 37.7
Shoulder 27 35.1
Arm-hand 23 29.9
Thoracic spine 21 27.3
Lumbar spine 36 46.8
Hip-thigh 14 18.2
Knee 21 27.3
Calf-foot 13 16.9
Stomach 23 29.9
Head 20 26.0
Table 2 SF-36 Scores With Regard To Pain Group (NCP, CRP, CWP) At Follow-Up For All 77 Women
n PF RP BP GH VT SF RE MH
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
NCP 18 93.3 (8.9) 72.2 (43.6) 76.4 (32.3) 77.1 (14.9) 60.0 (17.7) 74.3 (25.9) 63.0 (41.0) 68.4 (18.1)
CRP 34 87.7 (14.1) 67.4 (39.3) 71.0 (24.7) 65.0 (18.6) 45.4 (21.1) 77.9 (23.8) 60.6 (41.2) 61.2 (22.4)
CWP 25 76.4 (21.7) 58.3 (44.0) 50.0 (24.9) 53.3 (24.1) 36.5 (26.6) 68.8 (33.0) 50.0 (46.1) 57.0 (21.0)
p 0.003 0.542 0.003 0.001 0.005 0.459 0.551 0.220
Note: p = Significance for between-group differences in ANOVA analyses.
Dovepress Asztély et al
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children (26% of the total sample) had clinical features of
either ASD or ADHD, or both disorders. Among children
with ASD traits, girls were overrepresented, but among
children with ADHD traits, there was no gender differ-
ence. These findings are in agreement with those of the
Spanish study comparing women with fibromyalgia with
an age-matched group of healthy women. The diagnosis in
retrospect of childhood ADHD was made using a semi-
structured interview that contained DSM-IV criteria for
ADHD. A history of childhood ADHD was found to be
more common in those with fibromyalgia (32.3% and
2.52%, respectively).25
The reported pain locations in our study group are
consistent with reports from women of similar age in the
general population.19 This parallels findings noted in the
above-mentioned study of children in a pain clinic; pain
intensity, pain duration, pain frequency, pain sites, and
perceived reasons for pain did not differ between children
with and without clinically significant traits of ADHD or
ASD.38 From a clinical perspective, this means that
women with AD/ADHD, whether diagnosed or not,
could be expected to frequently seek care for the same
type and location of pain as women in the rest of the
population.
Headache and abdominal pain were common in this
group of women. Both pain types were more frequent in
women who also reported CWP or CRP, but they were
frequent also in those who did not. There has been a
number of studies about gastrointestinal problems and/or
headache being common among children with ASD and/or
ADHD, but few studies concerning adults. In the Danish
Blood Donor Study with 26,456 participants (median age:
42 years, IQR = 30–52 years), migraine was strongly
associated with ADHD (OR = 1.8, 95% CI = 1.5–2.1).
There was a significant interaction between age and gen-
der, with comorbidity increasing with age and female
sex.39 In a retrospective prevalence study, from three gen-
eral hospital and one paediatric hospital records, including
over 14,000 individuals under age 35 with ASD, 11.7%
had comorbid bowel disorders (excluding those with
inflammatory bowel disease).40 In our study, three-quarters
of the women reporting problems with headache and
abdominal pain also indicated CWP.
Reports of pain appear similar in women with or with-
out current health care contacts, suggesting that medical
services were unable to address or successfully treat pain
issues. However, among women with childhood ADHD,
CWP was less prevalent in those with ongoing stimulant
medication compared with those without. A recent study
suggested that adults with ADHD are more sensitive to
pain compared with controls and that methylphenidate
may affect acute pain responses in these subjects.41 In a
case report by Wiwe et al, severe chronic pain in a young
girl with undiagnosed comorbid ASD and ADHD, pain
and function were improved, following methylphenidate
medication and parental behavioural training.42 These
findings are also consistent with a case report describing
an adult woman treated with dexamphetamine.43
The women in our study had lower SF-36 scores than a
comparable general population. The women with ASD
and/or ADHD who did not report chronic pain scored
about the same in SF-36 as the general population except
for the mental spectrum (SF, RE, and MH). Those with
chronic pain scored overall lower than the general popula-
tion. This was especially prominent for those with CWP.
Although SF-36 is a generic HRQoL survey of patients
perceived quality of life that frequently has been used to
assess HRQoL in adults with ADHD, either solely or in
combination with ADHD-specific HRQoL measures. We
could identify no previous studies regarding the influence
of chronic pain in adults with autism and/or ADHD on
HRQoL for comparison. In several studies where HRQoL
has been assessed, it has been seen that individuals with
ADHD generally report lower score numbers. Using SF-36
it was found that adults with untreated ADHD had signifi-
cantly lower scores than the normal population regarding the
components V, SF, RE, and MH (mental components).44,45
The number of participants in our study is relatively
small, and another possible limitation is that we did not
include a healthy control group. Instead, we have dis-
cussed our results in relation to previous research includ-
ing a group of same age women from a population study in
Figure 2 SF-36 scores for the different pain groups at follow up for all 77 women,
with Swedish norm.
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a nearby part of Sweden. Nevertheless, our study has
several strengths. The original clinical cohort was well-
characterized; rigorous diagnostics criteria were applied.
The drop-out rate can be considered low, especially for
this type of longitudinal follow-up study. Validated instru-
ments were used to enable comparison with population
norms. Another strength is our use of a figure with pre-
defined body regions to examine pain, as it was assumed
that some of the participants might otherwise experience
difficulties in reporting their pain issues. Further, indivi-
dualized instruction was given by the attending examinee,
facilitating adequate responses.
Girls with ASD in the original study were referred at a
lower age compared to the ADHD group. This could be
explained by the early occurrence of qualitative impair-
ments in several areas of development in ASD. Girls with
ADHD, the majority above 11 years when included, were
assumed to be late referrals partly explained because girls
do not have the same disruptive acting out problems as
boys, therefore more difficult to detect.16
Conclusions
A large majority of the women with ASD and/or ADHD in
our study reported chronic pain, regional or widespread, that
to a great extent also impaired their HRQoL. While having
chronic pain was not related to having a health care contact
per se, the prevalence of chronic pain was lower in those that
were prescribed stimulants. Our findings highlight the impor-
tance of the health care professionals to address pain pro-
blems in this patient group and possible unrecognized ASD
and/or ADHD in women with chronic pain. Collaboration
among clinicians in primary care, psychiatry, and rheumatol-
ogy could facilitate treatment for women with ASD and/or
ADHD and comorbid pain conditions. Randomized con-
trolled trials regarding stimulant treatment of concomitant
chronic pain in ADHD are needed.
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